Revisiting the physiological effects of methylene blue as a treatment of cyanide intoxication

References

• Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med. 1991;325:1761–1766.
   PubMed Web of Science ®Google Scholar
• Tagwireyi D, Chingombe P, Khoza S, et al. Pattern and epidemiology of poisoning in the east african region: a literature review. J Toxicol. 2016;2016:1.
   Google Scholar
• Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol. 2007;26:191–201.
   PubMed Web of Science ®Google Scholar
• Borron SW, Baud FJ. Antidotes for acute cyanide poisoning. CPB 2012;13:1940–1948.
   Google Scholar
• Bebarta VS. Antidotes for cyanide poisoning. Eur J Emerg Med. 2013;20:65–66.
   PubMedGoogle Scholar
• Borron SW, Baud FJ, Megarbane B, et al. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. 2007;25:551–558.
   PubMed Web of Science ®Google Scholar
• Bebarta VS, Pitotti RL, Dixon PS, et al. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Ann Emerg Med. 2012;60:415–422.
   PubMed Web of Science ®Google Scholar
• Lee J, Mahon SB, Mukai D, et al. The vitamin B12 analog cobinamide is an effective antidote for oral cyanide poisoning. J Med Toxicol. 2016;12:370–379.
   PubMed Web of Science ®Google Scholar
• Baskin SI, Horowitz AM, Nealley EW. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol. 1992;32:368–375.
   PubMed Web of Science ®Google Scholar
• Bebarta VS, Brittain M, Chan A, et al. Sodium nitrite and sodium thiosulfate are effective against acute cyanide poisoning when administered by intramuscular injection. Ann Emerg Med. 2017;69:718–725 e714.
   PubMed Web of Science ®Google Scholar
• Cambal LK, Swanson MR, Yuan Q, et al. Acute, sublethal cyanide poisoning in mice is ameliorated by nitrite alone: complications arising from concomitant administration of nitrite and thiosulfate as an antidotal combination. Chem Res Toxicol. 2011;24:1104–1112.
   PubMed Web of Science ®Google Scholar
• Cambal LK, Weitz AC, Li HH, et al. Comparison of the relative propensities of isoamyl nitrite and sodium nitrite to ameliorate acute cyanide poisoning in mice and a novel antidotal effect arising from anesthetics. Chem Res Toxicol. 2013;26:828–836.
   PubMed Web of Science ®Google Scholar
• Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?. Ann Emerg Med. 2007;49:806–813.
   PubMed Web of Science ®Google Scholar
• Hall AH, Doutre WH, Ludden T, et al. Nitrite/thiosulfate treated acute cyanide poisoning: estimated kinetics after antidote. J Toxicol Clin Toxicol. 1987;25:121–133.
   PubMed Web of Science ®Google Scholar
• Hall AH, Rumack BH. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med. 1987;5:115–121.
   PubMedGoogle Scholar
• Patterson SE, Moeller B, Nagasawa HT, et al. Development of sulfanegen for mass cyanide casualties. Ann N Y Acad Sci. 2016;1374:202–209.
   PubMed Web of Science ®Google Scholar
• Patterson SE, Monteil AR, Cohen JF, et al. Cyanide antidotes for mass casualties: water-soluble salts of the dithiane (sulfanegen) from 3-mercaptopyruvate for intramuscular administration. J Med Chem. 2013;56:1346–1349.
   PubMed Web of Science ®Google Scholar
• Geiger JC. Cyanide poisoning in San Francisco. JAMA. 1932;99:1944–1945.
   Google Scholar
• Sahlin B. The antagonism between methylene blue and cyan potassium. Skandinavisches Archiv Fur Physiologie. 1926;47:284–291.
   Google Scholar
• Eddy NB. Antagonism between methylene blue and sodium cyanide. J Pharmacol & Exper Therap 1930;39:271.
   Google Scholar
• Brooks MM. Methylene blue as antidote for cyanide and carbon monoxide poisoning. JAMA. 1933;100:59.
   Google Scholar
• Brooks MM. The mechanism of methylene blue action on blood. Science 1934;80:15–16.
   PubMedGoogle Scholar
• Wendel WB. The mechanism of antidotal action of methylene blue in cyanide poisoning. Science 1934;80:381–382.
   Google Scholar
• Wendel WB. The control of methemoglobinemia with methylene blue. J Clin Invest. 1939;18:179–185.
   PubMedGoogle Scholar
• Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010;26:517–520.
   PubMedGoogle Scholar
• Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646–656.
   PubMed Web of Science ®Google Scholar
• Chen KK, Rose CL. Nitrite and thiosulfate therapy in cyanide poisoning. J Am Med Assoc. 1952;149:113–119.
   PubMed Web of Science ®Google Scholar
• Sevcik P, Dunford HB. Kinetics of the oxidation of NADH by methylene blue in a closed system. J Phys Chem. 1991;95: 2411–2415.
   Web of Science ®Google Scholar
• Engbersen JFJ, Koudijs A, Van der Plas HC. Reaction of NADH models with methylene blue. Recl Trav Chim Pays-Bas. 2010; 104:131–138.
   Google Scholar
• Clifton J, 2nd, Leikin JB. Methylene blue. Am J Ther. 2003;10:289–291.
   PubMedGoogle Scholar
• Schirmer RH, Adler H, Pickhardt M, et al. Lest we forget you–methylene blue…. Neurobiol Aging. 2011;32:2325 2325.e7–2316.
   PubMed Web of Science ®Google Scholar
• Buchholz K, Schirmer RH, Eubel JK, et al. Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum. Antimicrob Agents Chemother. 2008;52:183–191.
   PubMed Web of Science ®Google Scholar
• Peter C, Hongwan D, Kupfer A, et al. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol. 2000;56:247–250.
   PubMed Web of Science ®Google Scholar
• Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012;96:32–45.
   PubMed Web of Science ®Google Scholar
• Komlodi T, Tretter L. Methylene blue stimulates substrate-level phosphorylation catalysed by succinyl-CoA ligase in the citric acid cycle. Neuropharmacology 2017;123:287–298.
   PubMed Web of Science ®Google Scholar
• Wen Y, Li W, Poteet EC, et al. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem. 2011;286:16504–16515.
   PubMed Web of Science ®Google Scholar
• Zhang X, Rojas JC, Gonzalez-Lima F. Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox Res. 2006;9:47–57.
   PubMed Web of Science ®Google Scholar
• Daudt DR, 3rd, Mueller B, Park YH, et al. Methylene blue protects primary rat retinal ganglion cells from cellular senescence. Invest Ophthalmol Vis Sci. 2012;53:4657–4667.
   PubMed Web of Science ®Google Scholar
• Atamna H, Nguyen A, Schultz C, et al. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. Faseb J. 2007;22:703–712.
   PubMed Web of Science ®Google Scholar
• Poteet E, Winters A, Yan LJ, et al. Neuroprotective actions of methylene blue and its derivatives. PloS One. 2012;7:e48279
   PubMed Web of Science ®Google Scholar
• Haouzi P, Tubbs N, Rannals MD, et al. Circulatory failure during noninhaled forms of cyanide intoxication. Shock 2017;47:352–362.
   PubMed Web of Science ®Google Scholar
• Haouzi P, Van de Louw A. Uncoupling mitochondrial activity maintains body VO2 during hemorrhage-induced O2 deficit in the anesthetized rat. Respir Physiol Neurobiol. 2013;186:87–94.
   PubMed Web of Science ®Google Scholar
• Klingerman CM, Trushin N, Prokopczyk B, et al. H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing. Am J Physiol Regul Integr Comp Physiol. 2013;305:R630–R638.
   PubMed Web of Science ®Google Scholar
• Haouzi P, Van de Louw A. Persistent reduced oxygen requirement following blood transfusion during recovery from hemorrhagic shock. Respir Physiol Neurobiol. 2015;215:39–46.
   PubMed Web of Science ®Google Scholar
• Lundquist P, Sorbo B. Rapid determination of toxic cyanide concentrations in blood. Clin Chem. 1989;35:617–619.
   PubMed Web of Science ®Google Scholar
• Harrop GA, Barron ES. Studies on blood cell metabolism: I. The effect of methylene blue and other dyes upon the oxygen consumption of mammalian and avian erythrocytes. J Exp Med. 1928;48:207–223.
   PubMedGoogle Scholar
• Barron ES. The catalytic effect of methylene blue on the oxygen consumption of tumors and normal tissues. J Exp Med. 1930;52:447–456.
   PubMedGoogle Scholar
• Bodine JH, Lu KH. Methylene blue, 2,4-dinitrophenol, and oxygen uptake of intact and homogenized embryos. Proc Soc Exp Biol Med. 1950;74:448–450.
   PubMed Web of Science ®Google Scholar
• Levine S. Interaction between ethyl methylene blue and cyanide-induced increases in blood lactate. J Lab Clin Med 1977;89:632–639.
   PubMed Web of Science ®Google Scholar
• Tranquada RE, Bernstein S, Grant WJ. Intravenous methylene blue in the therapy of lactic acidosis. Arch Intern Med. 1964;114:13–25.
   PubMedGoogle Scholar
• Hall AH, Saiers J, Baud F. Which cyanide antidote?. Crit Rev Toxicol. 2009;39:541–552.
   PubMed Web of Science ®Google Scholar
• Burrows GE. Methylene blue: effects and disposition in sheep. J Vet Pharmacol Ther. 1984;7:225–231.
   PubMed Web of Science ®Google Scholar
• Stossel TP, Jennings RB. Failure of methylene blue to produce methemoglobinemia in vivo. Am J Clin Pathol. 1966;45:600–604.
   PubMed Web of Science ®Google Scholar
• Kohn MC, Melnick RL, Ye F, et al. Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat. Drug Metab Dispos. 2002;30:676–683.
   PubMed Web of Science ®Google Scholar
• Shou Y, Gunasekar PG, Borowitz JL, et al. Cyanide-induced apoptosis involves oxidative-stress-activated NF-kappaB in cortical neurons. Toxicol Appl Pharmacol. 2000;164:196–205.
   PubMed Web of Science ®Google Scholar
• Mills EM, Gunasekar PG, Pavlakovic G, et al. Cyanide-induced apoptosis and oxidative stress in differentiated PC12 cells. J Neurochem. 1996;67:1039–1046.
   PubMed Web of Science ®Google Scholar
• Gunasekar PG, Sun PW, Kanthasamy AG, et al. Cyanide-induced neurotoxicity involves nitric oxide and reactive oxygen species generation after N-methyl-D-aspartate receptor activation. J Pharmacol Exp Ther. 1996;277:150–155.
   PubMed Web of Science ®Google Scholar
• Gunasekar PG, Borowitz JL, Isom GE. Cyanide-induced generation of oxidative species: involvement of nitric oxide synthase and cyclooxygenase-2. J Pharmacol Exp Ther. 1998;285:236–241.
   PubMed Web of Science ®Google Scholar
• Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res. 2006;71:310–321.
   PubMed Web of Science ®Google Scholar
• Judenherc-Haouzi A, Zhang XQ, Sonobe T, et al. Methylene blue counteracts H2S toxicity-induced cardiac depression by restoring L-type Ca channel activity. Am J Physiol Regul Integr Comp Physiol. 2016;310:R1030–R1044.
   PubMed Web of Science ®Google Scholar
• Scott A, Hunter FE. Support of thyroxine-induced swelling of liver mitochondria by generation of high energy intermediates at any one of three sites in electron transport. J Biol Chem 1966;241:1060–1066.
   PubMed Web of Science ®Google Scholar
• Visarius TM, Stucki JW, Lauterburg BH. Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett. 1997;412:157–160.
   PubMed Web of Science ®Google Scholar
• Callaway NL, Riha PD, Wrubel KM, et al. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett. 2002;332:83–86.
   PubMed Web of Science ®Google Scholar
• Ryou MG, Choudhury GR, Li W, et al. Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress. Neuroscience 2015;301:193–203.
   PubMed Web of Science ®Google Scholar
• Herman MI, Chyka PA, Butler AY, et al. Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med. 1999;33:111–113.
   PubMed Web of Science ®Google Scholar
• Reyes F, Noelck M, Valentino C, et al. Complications of methylene blue dye in breast surgery: case reports and review of the literature. J Cancer. 2010;2:20–25.
   PubMed Web of Science ®Google Scholar
• Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics 2010;51:194–200.
   PubMed Web of Science ®Google Scholar
• Grubb KJ, Kennedy JL, Bergin JD, et al. The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg. 2012;144:e113–e116.
   PubMed Web of Science ®Google Scholar
• Wainwright M, Amaral L. The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop Med Int Health. 2005;10:501–511.
   PubMed Web of Science ®Google Scholar
• Meissner PE, Mandi G, Witte S, et al. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malar J 2005;4:45.
   PubMed Web of Science ®Google Scholar
• Mandi G, Witte S, Meissner P, et al. Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop Med Int Health. 2005;10:32–38.
   PubMed Web of Science ®Google Scholar
• Muller O, Meissner P, Mansmann U. Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue. Drug Saf 2012;35:85. Author reply 85–86.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services FaDA: Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers Edited by CDER, 2005. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm078932.pdf
   Google Scholar